Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis (Q34813994)

4 August 2017

title

Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis (English)

1 reference

4 August 2017

0 references

1 reference

Elizabeth Joseloff

1

1 reference

4 August 2017

Wei Sha

2

1 reference

4 August 2017

Sara C Bell

3

1 reference

4 August 2017

Diana R Wetmore

4

1 reference

4 August 2017

Kay A Lawton

5

1 reference

4 August 2017

Michael V Milburn

6

1 reference

4 August 2017

John A Ryals

7

1 reference

4 August 2017

Lining Guo

8

1 reference

4 August 2017

Marianne S Muhlebach

9

1 reference

4 August 2017

publication date

12 July 2013

1 reference

4 August 2017

published in

Pediatric Pulmonology

1 reference

4 August 2017

volume

49

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

463-472

1 reference

Lower airway inflammation in infants and young children with cystic fibrosis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Energy expenditure of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Dysfunction of mitochondria Ca2+ uptake in cystic fibrosis airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

The Mitochondrial Barriers Segregate Agonist-induced Calcium-dependent Functions in Human Airway Epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Calcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Serum Lipoprotein Concentrations in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Association of cystic fibrosis with abnormalities in fatty acid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Fatty acid metabolism in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

The measurement of carnitine and acyl-carnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

The formation of 2-hydroxybutyric acid in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that res

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Evidence for a mitochondrial lesion in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Lipid metabolism in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

New lipidomic approaches in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Disaccharides and cystic fibrosis of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Individual variation in macronutrient regulation measured by proton magnetic resonance spectroscopy of human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22859

21 January 2018

Identifiers

DOI

10.1002/PPUL.22859

1 reference

4 August 2017

1 reference